Literature DB >> 29115694

Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.

Stephen J Marx1.   

Abstract

Familial hypocalciuric hypercalcemia (FHH) causes lifelong hypercalcemia with features that overlap with typical primary hyperparathyroidism (PHPT). The incompleteness of this overlap has led to divergent nomenclatures for FHH. I compare two nomenclatures. One sets FHH as an entity distinct from PHPT. The other groups FHH with PHPT but conditions FHH as atypical PHPT. I analyzed selected articles about calcium-sensing receptors, FHH, PHPT, CASR, GNA11, and AP2S1. FHH usually results from a heterozygous germline inactivating mutation of the CASR, and less frequently from mutation of GNA11 or AP2S1. The CASR encodes the calcium-sensing receptors. These are highly expressed on parathyroid cells, where they sense serum calcium concentration and regulate suppression of PTH secretion by serum calcium. Their mutated expression in the kidney in FHH causes increased renal tubular reabsorption of calcium (hypocalciuria). Many FHH features are shared with PHPT and thus support FHH as a form of PHPT. These include a driver mutation expressed mainly in the parathyroid cells. The mutation causes a parathyroid cell insensitivity to extracellular calcium in vivo and in vitro, a right-shift of the set point for suppression of PTH secretion by calcium. Serum PTH is normal or mildly elevated; ie, it is not appropriately suppressed by hypercalcemia. Total parathyroidectomy causes hypoparathyroidism and durable remission of hypercalcemia. Some other features are not shared with PHPT and could support FHH as a distinct entity. These include onset of hypercalcemia in the first week of life, frequent persistence of hypercalcemia after subtotal parathyroidectomy, and hypocalciuria. The features supporting FHH as a form of PHPT are stronger than those favoring FHH as a distinct entity. Classifying FHH as an atypical form of PHPT represents compact nomenclature and supports current concepts of pathophysiology of FHH and PHPT. Published 2017. This article is a U.S. Government work and is in the public domain in the USA. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  CALCIUM SENSING RECEPTOR; CASR; FHH; HYPERPARATHYROID

Mesh:

Substances:

Year:  2017        PMID: 29115694     DOI: 10.1002/jbmr.3339

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

Review 1.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

2.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 3.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 4.  Familial hypocalciuric hypercalcemia and related disorders.

Authors:  Janet Y Lee; Dolores M Shoback
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

5.  Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.

Authors:  Noriko Makita; Takao Ando; Junichiro Sato; Katsunori Manaka; Koji Mitani; Yasuko Kikuchi; Takayoshi Niwa; Masanori Ootaki; Yuko Takeba; Naoki Matsumoto; Atsushi Kawakami; Toshihisa Ogawa; Masaomi Nangaku; Taroh Iiri
Journal:  JCI Insight       Date:  2019-04-18

6.  Single Gland, Ectopic Location: Adenomas are Common Causes of Primary Hyperparathyroidism in Children and Adolescents.

Authors:  Robert D Rampp; Edna E Mancilla; N Scott Adzick; Michael A Levine; Rachel R Kelz; Douglas L Fraker; Pallavi Iyer; Brenessa M Lindeman; Vicente A Mejia; Herbert Chen; Heather Wachtel
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

Review 7.  The role of calcium-sensing receptor signaling in regulating transepithelial calcium transport.

Authors:  Rebecca Siu Ga Tan; Christy Hui Lin Lee; Henrik Dimke; R Todd Alexander
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

8.  Misleading localization by 18F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report.

Authors:  Noha N Mukhtar; Mohei El-Din M Abouzied; Mohammed H Alqahtani; Muhammad M Hammami
Journal:  BMC Endocr Disord       Date:  2021-01-26       Impact factor: 2.763

9.  Double jeopardy: a patient's tale of two concurrent hypercalcaemic syndromes.

Authors:  Aditi Sharma; Fatima Bahowairath; Chukwuma Uduku; Julia E Ostberg
Journal:  BMJ Case Rep       Date:  2020-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.